Medly for Heart Failure

Phase-Based Progress Estimates
Michael Garron Hospital, Toronto, CanadaHeart FailureMedly - Device
All Sexes
What conditions do you have?

Study Summary

This trial will test a new smartphone app, Medly, for patients recently diagnosed with heart failure. The app is designed to help manage self-care and improve quality of life. The trial will measure if the app leads to a reduction in 30-day readmissions rates, without increasing the average length of stay or visits to the emergency department.

Treatment Effectiveness

Study Objectives

5 Primary · 3 Secondary · Reporting Duration: Baseline, 2 weeks, 1 month, 3 months

0 - 3 months
Hospital length of stay
Number of visits to the emergency department
1 month
30-day HF readmission rate
3 months
Compliance with Medly utilization
Month 3
Change BNP/NT-pro BNP levels
Safety Endpoint: Change in creatinine levels
Safety Endpoint: Change in potassium levels
Safety Endpoint: Change in sodium levels
Baseline, 3 months
Change in NYHA class
Change in quality of life
Change in self-care of health failure

Trial Safety

Trial Design

2 Treatment Groups

1 of 2
Telemonitoring (Medly)
1 of 2

Active Control

Experimental Treatment

144 Total Participants · 2 Treatment Groups

Primary Treatment: Medly · No Placebo Group · N/A

Telemonitoring (Medly)
Experimental Group · 1 Intervention: Medly · Intervention Types: Device
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 2 weeks, 1 month, 3 months

Who is running the clinical trial?

North York General HospitalOTHER
19 Previous Clinical Trials
8,820 Total Patients Enrolled
University Health Network, TorontoLead Sponsor
1,386 Previous Clinical Trials
471,850 Total Patients Enrolled
23 Trials studying Heart Failure
17,491 Patients Enrolled for Heart Failure
Sunnybrook Health Sciences CentreOTHER
607 Previous Clinical Trials
1,468,099 Total Patients Enrolled
5 Trials studying Heart Failure
46,664 Patients Enrolled for Heart Failure
35 Previous Clinical Trials
11,874 Total Patients Enrolled
Emily Seto, PhDPrincipal InvestigatorUniversity of Toronto
2 Previous Clinical Trials
158 Total Patients Enrolled
1 Trials studying Heart Failure
108 Patients Enrolled for Heart Failure

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

What is the upper limit of enrollees for this clinical investigation?

"Affirmative. Based on the information available from, this research venture is recruiting participants as we speak. The trial was first uploaded in November 2018 and has been updated just recently in March 2022; it is seeking 144 volunteers across 4 sites for involvement." - Anonymous Online Contributor

Unverified Answer

Are there any opportunities for recruitment in this clinical trial?

"According to the information stored on, this trial is currently in need of participants and was created on November 16th 2018 before being amended most recently on March 9th 2022." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.